Literature DB >> 17128202

Intravitreal bevacizumab (Avastin) for choroidal metastasis secondary to breast carcinoma: short-term follow-up.

L Amselem, E Cervera, M Díaz-Llopis, J Montero, M Garcia-Pous, P Udaondo, S García-Delpech, D Salom.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17128202     DOI： 10.1038/sj.eye.6702647

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  18 in total

1.  Intravitreal bevacizumab for choroidal metastases: the key to efficacy is simultaneous administration of systemic therapy.

Authors:  N Singh; R Bansal; D Behera; A Gupta
Journal:  Eye (Lond)       Date:  2015-09-18       Impact factor: 3.775

2.  Intravitreal bevacizumab in the successful management of choroidal metastases secondary to lung and breast cancer unresponsive to systemic therapy: a case series.

Authors:  V Fenicia; S Abdolrahimzadeh; G Mannino; S Verrilli; M Balestrieri; S M Recupero
Journal:  Eye (Lond)       Date:  2014-04-25       Impact factor: 3.775

Review 3.  Combination of intravitreal bevacizumab and systemic therapy for choroidal metastases from lung cancer: report of two cases and a systematic review of literature.

Authors:  Venkata Nagarjuna Maturu; Navneet Singh; Pooja Bansal; Bhagwant Rai Mittal; Nalini Gupta; Digambar Behera; Amod Gupta
Journal:  Med Oncol       Date:  2014-03-07       Impact factor: 3.064

Review 4.  Emerging treatments for choroidal metastases.

Authors:  Connie J Chen; Allison N McCoy; Julie Brahmer; James T Handa
Journal:  Surv Ophthalmol       Date:  2011 Nov-Dec       Impact factor: 6.048

5.  Intravitreal bevacizumab for consecutive multiple choroidal breast metastatic lesions.

Authors:  Ahmad M Mansour; Ramzi Alameddine
Journal:  BMJ Case Rep       Date:  2012-06-14

6.  The toxicity of intrathecal bevacizumab in a rabbit model of leptomeningeal carcinomatosis.

Authors:  Priscilla K Brastianos; Harry C Brastianos; Wesley Hsu; Daniel M Sciubba; Thomas Kosztowski; Betty M Tyler; Violette Renard Recinos; Peter Burger; Stuart A Grossman
Journal:  J Neurooncol       Date:  2011-07-26       Impact factor: 4.130

7.  Failure of intravitreal bevacizumab in the treatment of choroidal metastasis.

Authors:  A Maudgil; K S Sears; P A Rundle; I G Rennie; S M Salvi
Journal:  Eye (Lond)       Date:  2015-03-13       Impact factor: 3.775

8.  Bevacizumab suppression of establishment of micrometastases in experimental ocular melanoma.

Authors:  Hua Yang; Martine J Jager; Hans E Grossniklaus
Journal:  Invest Ophthalmol Vis Sci       Date:  2010-01-20       Impact factor: 4.799

9.  Treatment of choroid metastasis from lung adenocarcinoma with bevacizumab-containing chemotherapy: A case report.

Authors:  Kenichi Makabe; Koichi Kurishima; Toshihiro Shiozawa; Kunihiko Miyazaki; Gen Ohara; Katsunori Kagohashi; Hiroaki Satoh; Nobuyuki Hizawa
Journal:  Exp Ther Med       Date:  2015-11-25       Impact factor: 2.447

10.  Adjuvant Intravitreal Bevacizumab Injection for Choroidal and Orbital Metastases of Refractory Invasive Ductal Carcinoma of the Breast.

Authors:  I-Hung Lin; Bo-I Kuo; Fang-Yu Liu
Journal:  Medicina (Kaunas)       Date:  2021-04-22       Impact factor: 2.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.